Insider Options Surge as Gain Therapeutics Prepares Phase 2 LaunchInsider option grants at Gain Therapeutics signal confidence in its allosteric platform and upcoming Phase 2 trials for systemic sclerosis.GAIN THERAPEUTICS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 17/07/2026, 14:49 5 minutes to read
